Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease

Kaposi sarcoma (KS) herpesvirus–associated multicentric Castleman disease (KSHV-MCD) is a lymphoproliferative disorder, most commonly seen in HIV-infected patients, that has a high mortality if untreated. Concurrent KS is common. Although rituximab has reported activity in KSHV-MCD, its use is often...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Blood
Autores principales: Uldrick, Thomas S., Polizzotto, Mark N., Aleman, Karen, Wyvill, Kathleen M., Marshall, Vickie, Whitby, Denise, Wang, Victoria, Pittaluga, Stefania, O’Mahony, Deirdre, Steinberg, Seth M., Little, Richard F., Yarchoan, Robert
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2014
Materias:
Clinical Trials and Observations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4256906/
https://ncbi.nlm.nih.gov/pubmed/25331113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-07-586800
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares